Don’t miss the latest developments in business and finance.

Infinium Pharmachem Ltd - IPO

Issue Type

Fixed Price - SME

Issue Size (₹ Cr.)

₹ 25.26

Price Range (₹)

₹ 135

Lot Size

1000

Min Investment (₹)

₹ 1,35,000.00

Listing Exchange

NSE - SME

Open Date

31-Mar-2023

Close Date

05-Apr-2023

Listing Date

17-Apr-2023

Infinium Pharmachem Ltd News

Infinium Pharmachem Ltd IPO Details

Public issue of upto 18,75,000 equity shares of face value of Rs. 10/- each of Infinium Pharmachem Limited (Infinium or the Company or the Issuer) for cash at a price of Rs. 135/-* per equity share including a share premium of Rs. 125/- per equity share (the Issue Price) aggregating to Rs. 25.26 crores (The Issue), of which 41,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 121.50/-* each aggregating to Rs. 0.50 crores will be reserved for subscription by eligible employees [other than promoter and promoter group] of the issuer (the Employees Reservation Portion) and 94,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 135/- per equity share including a share premium of Rs. 125/- per equity share aggregating to Rs. 1.27 crores will be reserved for subscription by market maker to the issue (the Market Maker Reservation Portion). The issue less the market maker reservation portion and employees reservation portion i.e. net issue of 17,40,000 equity shares of face value of Rs. 10/- each at a price of Rs. 135/- per equity share including a share premium of Rs. 125/- per equity share aggregating to Rs. 23.49 crores is herein after referred to as the Net Issue. The issue and the net issue will constitute 26.95% and 25.01% respectively of the post issue paid up equity share capital of the company.*The company in consultation with the lead manager, have offered a discount of Rs. 13.50/- per equity share to eligible employees bidding in the employee reservation portion.The face value of the equity shares is Rs. 10 each and the issue price is Rs 135/-. The issue price is 13.5 times of the face value.3

Objective of issue

Marketing & Branding Expenses (including Registrations, Reach-Europe, other marketing expenses).. Repayment of some Existing Loans. Expansion of Existing Unit. To Meet Incremental Working Capital Requirements. General Corporate Purposes.

Infinium Pharmachem Ltd Contact Details

Infinium Pharmachem Ltd, Office No 56-2, Pinnacle Busine.Park, Mahakali Caves Road, Mumbai - 400093

Phone - 91-22-62638200

Fax - 91-22-63638299

Email - cs@infiniumpharmachem.com

Website - https:, infiniumpharmachem.com